Filing Details

Accession Number:
0001079973-10-000785
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-27 13:00:00
Reporting Period:
2010-07-26
Filing Date:
2010-07-27
Accepted Time:
2010-07-27 09:43:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1167419 Aspenbio Pharma Inc. APPY In Vitro & In Vivo Diagnostic Substances (2835) 841553387
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187604 Jeffrey Mcgonegal 1585 S. Perry Street
Castle Rock CO 80104
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-07-26 15,000 $0.71 239,031 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,500 Indirect By child